Retinoblastoma treatment: impact of the glycolytic inhibitor 2-deoxy-d-glucose on molecular genomics expression in LH(BETA)T(AG) retinal tumors.

Authors

Y Piña
S K. Houston
T G. Murray
T Koru-Sengul
C Decatur
W K. Scott
Lubov Nathanson, Nova Southeastern UniversityFollow
J Clarke
T J. Lampidis

Publication Title

Clinical ophthalmology (Auckland, N.Z.)

ISSN

1177-5467

Publication Date

1-1-2012

DOI

10.2147/OPTH.S29688

Volume

6

First Page

817

Last Page

30

Disciplines

Medical Specialties | Medicine and Health Sciences | Osteopathic Medicine and Osteopathy

NSUWorks Citation

Piña, Y; Houston, S K.; Murray, T G.; Koru-Sengul, T; Decatur, C; Scott, W K.; Nathanson, Lubov; Clarke, J; and Lampidis, T J., "Retinoblastoma treatment: impact of the glycolytic inhibitor 2-deoxy-d-glucose on molecular genomics expression in LH(BETA)T(AG) retinal tumors." (2012). Faculty Articles. 1249.
https://nsuworks.nova.edu/hpd_com_faculty_articles/1249